Fc-engineered EGF-R antibodies mediate improved antibody-dependent cellular cytotoxicity (ADCC) against KRAS-mutated tumor cells.
Schlaeth
Martin
M
Section for Stem Cell Transplantation and Immunotherapy, Christian-Albrechts-University and University Hospital Schleswig-Holstein, Kiel, Germany.
Berger
Sven
S
Derer
Stefanie
S
Klausz
Katja
K
Lohse
Stefan
S
Dechant
Michael
M
Lazar
Greg A
GA
Schneider-Merck
Tanja
T
Peipp
Matthias
M
Valerius
Thomas
T